MLRRX | RGAHX | MLRRX / RGAHX | |
Total Expense Ratio | N/A | N/A | - |
Annual Report Gross Expense Ratio | N/A | N/A | - |
Fund Existence | 19 years | 9 years | - |
Gain YTD | 15.941 | 15.702 | 102% |
Front Load | N/A | N/A | - |
Min. Initial Investment | 0 | 250 | - |
Min. Initial Investment IRA | N/A | N/A | - |
Net Assets | 13.6B | 270B | 5% |
Annual Yield % from dividends | 0.00 | 0.64 | - |
Returns for 1 year | 17.93 | 18.54 | 97% |
Returns for 3 years | -25.53 | -7.05 | 362% |
Returns for 5 years | 14.18 | 46.96 | 30% |
Returns for 10 years | 6.88 | N/A | - |
1 Day | |||
---|---|---|---|
ETFs / NAME | Price $ | Chg $ | Chg % |
STIP | 100.43 | 0.02 | +0.02% |
iShares 0-5 Year TIPS Bond ETF | |||
QTAP | 34.27 | -0.02 | -0.07% |
Innovator Growth-100 Acltd Ps ETF™ April | |||
CZA | 103.73 | -0.67 | -0.64% |
Invesco Zacks Mid-Cap ETF | |||
PFI | 53.18 | -0.46 | -0.85% |
Invesco Dorsey Wright Financial Momt ETF | |||
PPH | 97.24 | -1.67 | -1.69% |
VanEck Pharmaceutical ETF |